Handelsbanken Fonder’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
Other funds holding MGNX
BG
WA
RI
PA
Handelsbanken Fonder's MGNX Position: Q2 2022 in Review
Handelsbanken Fonder sold out of MacroGenics (MGNX) in Q2 2022, closing a stake of 16,400 shares — an estimated $144K sold.
Handelsbanken Fonder first reported a position in MGNX in Q1 2021 and held it in 5 quarters. The position peaked at $338K in Q2 2021. 133 funds tracked by Wall St. Rank hold MGNX as of Q2 2022.
- Handelsbanken Fonder reported no remaining MacroGenics position as of Q2 2022 after selling out during the quarter.
- Handelsbanken Fonder sold 16,400 MacroGenics shares in Q2 2022, an estimated $144K.
- Handelsbanken Fonder first reported a position in MacroGenics in Q1 2021 and held it in 5 quarters.
- Handelsbanken Fonder's MacroGenics position peaked at $338K in Q2 2021.
- 133 funds tracked by Wall St. Rank held MacroGenics as of Q2 2022.
Based on Handelsbanken Fonder's 13F filing for Q2 2022, filed 3 Aug 2022.